Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1990-03-01
1992-10-20
Schwartz, Richard A.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
4352523, 435255, 4353201, 435226, 536 27, C12N 964, C12N 1558, C12N 1500, C12N 510, C07H 2104
Patent
active
051569698
ABSTRACT:
A tissue plasminogen activator (t-PA) variant is prepared that has an amino acid deletion at positions 466 to 470 of the corresponding wild-type t-PA. This alteration renders the variant fibrin (and plasma clot) specific as compared to the corresponding wild-type t-PA. DNA sequences can be prepared that encode the variant, as well as expression vectors incorporating the DNA sequences, and host cells transformed with the expression vectors. The variant may be used in a pharmaceutical preparation to treat a vascular disease or condition or to prevent fibrin deposition or adhesin formation or reformation in mammals.
Gill John F.
Presta Leonard G.
Zoller Mark J.
Genentech Inc.
Porta Marianne
Schwartz Richard A.
LandOfFree
Tissue plasminogen activator variant with deletion of amino acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tissue plasminogen activator variant with deletion of amino acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue plasminogen activator variant with deletion of amino acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-191511